LINC00958 exerts oncogenic properties in HCC by downregulating miR-3619-5p to upregulate hepatoma-derived growth factor (HDGF) expression, leading to reprogramming of lipid metabolism to promote HCC [56]. The gene discussed is HDGF; the disease is hepatocellular carcinoma.